Bin Cheng

Follow

Generating author description...

All published works
Action Title Year Authors
+ Dose Individualization for Phase I Cancer Trials With Broadened Eligibility 2024 Rebecca B. Silva
Bin Cheng
Richard D. Carvajal
Shing M. Lee
+ PDF Chat Low depth amplitude estimation without really trying 2024 Duy Vu
Bin Cheng
Patrick Rebentrost
+ Maximum Likelihood Estimation and Design and Inference Considerations for Sequential Multiple Assignment Randomized Trials 2024 Robert A. Tumasian
Bin Cheng
+ Precision Dose-finding Cancer Clinical Trials in the Setting of Broadened Eligibility 2023 Rebecca B. Silva
Bin Cheng
Richard D. Carvajal
Shing M. Lee
+ The common trend of saltation particles on the surface of fast-rotating asteroids 2023 Zhijun Song
Yang Yu
Bin Cheng
Lv Jing
Hexi Baoyin
+ Near Resonant Approximation of the Rotating Stratified Boussinesq system on a 3-Torus 2022 Bin Cheng
Zisis N. Sakellaris
+ Zero-inflated quantile rank-score based test (ZIQRank) with application to scRNA-seq differential gene expression analysis 2021 Wodan Ling
Wenfei Zhang
Bin Cheng
Ying Wei
+ Seamless phase I/II design for novel anticancer agents with competing disease progression 2021 Lucie Biard
Shing M. Lee
Bin Cheng
+ On likelihood ratio ordering of parallel systems with heterogeneous exponential components 2021 Jiantian Wang
Bin Cheng
+ SMARTAR: an R package for designing and analyzing Sequential Multiple Assignment Randomized Trials 2021 Xiaobo Zhong
Bin Cheng
Xinru Wang
Ying Kuen Cheung
+ Likelihood ratio ordering for parallel systems with exponential components 2021 Jiantian Wang
Bin Cheng
+ Long-term Trends of Regolith Movement on the Surface of Small Bodies 2021 Chenyang Huang
Y. Yu
Bin Cheng
Qingyun Wang
+ Near Resonance Approximation of Rotating Navier-Stokes Equations 2021 Bin Cheng
Zisis N. Sakellaris
+ PDF Chat A simulation study of approaches for handling disease progression in dose-finding clinical trials 2020 Lucie Biard
Bin Cheng
Gulam A. Manji
Shing M. Lee
+ Personalized Policy Learning Using Longitudinal Mobile Health Data 2020 Xinyu Hu
Min Qian
Bin Cheng
Ying Kuen Cheung
+ Comparing adaptive interventions under a general sequential multiple assignment randomized trial design via multiple comparisons with the best 2020 Xiaobo Zhong
Ying Kuen Cheung
Min Qian
Bin Cheng
+ Personalized Policy Learning using Longitudinal Mobile Health Data 2020 Xinyu Hu
Min Qian
Bin Cheng
Ying Kuen Cheung
+ Incorporating patient‐reported outcomes in dose‐finding clinical trials 2019 Shing M. Lee
Xiaoqi Lu
Bin Cheng
+ A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials 2019 Xiaobo Zhong
Bin Cheng
Min Qian
Ying Kuen Cheung
+ Adding dose modifications into Phase II and Phase II/III seamless trials 2019 John Spivack
Bin Cheng
Bruce Levin
+ A simulation study of methods for handling disease progression in dose-finding clinical trials 2019 Lucie Biard
Bin Cheng
Gulam A. Manji
Shing M. Lee
+ An Interior A Priori Estimate for Solutions to Monge-Ampùre Equations with Right-Hand Side Close to One 2019 Thomas J. O’Neill
Bin Cheng
+ Limb-Leaf designs for adaptive exploration of the dose-response curve 2017 John Spivack
Bin Cheng
Bruce Levin
+ Stochastic comparison of parallel systems with heterogeneous exponential components 2017 Bin Cheng
Jiantian Wang
+ Answer to an open problem on mean residual life ordering of parallel systems under multiple-outlier exponential models 2017 Jiantian Wang
Bin Cheng
+ Estimating odds ratios under a case-background design with an application to a study of Sorafenib accessibility 2016 John Spivack
Bin Cheng
+ On the consistency of the continual reassessment method with multiple toxicity constraints 2015 Bin Cheng
Shing M. Lee
+ PDF Chat A note on confidence bounds after fixed-sequence multiple tests 2012 Yi-Hsuan Tu
Bin Cheng
Ying Kuen Cheung
+ On Flexibility of Adaptive Designs and Criteria for Choosing A Good One—A Discussion of FDA Draft Guidance 2010 Bin Cheng
Shein‐Chung Chow
+ PDF Chat Continual reassessment method with multiple toxicity constraints 2010 S. M. Lee
Bin Cheng
Ying Kuen Cheung
+ On Power and Sample Size Calculation for QT Studies with Recording Replicates at Given Time Point 2008 Shein‐Chung Chow
Bin Cheng
Dennis Cosmatos
+ Statistical Assessment of QT/QTc Prolongation Based on Maximum of Correlated Normal Random Variables 2008 Bin Cheng
Shein‐Chung Chow
David Burt
Dennis Cosmatos
+ An identity of Stirling numbers of the second kind 2008 Bin Cheng
+ On the Assessment of Dose Proportionality: A Comparison of Two Slope Approaches 2006 Bin Cheng
Shein‐Chung Chow
Wei‐Lun Su
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat Model calibration in the continual reassessment method 2009 Shing M. Lee
Ying Kuen Cheung
7
+ Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer 1990 John O’Quigley
Margaret S. Pepe
Lloyd D. Fisher
5
+ PDF Chat Sequential Multiple Assignment Randomized Trial (SMART) with Adaptive Randomization for Quality Improvement in Depression Treatment Program 2014 Ying Kuen Cheung
Bibhas Chakraborty
Karina W. Davidson
5
+ PDF Chat Design of sequentially randomized trials for testing adaptive treatment strategies 2015 Semhar Ogbagaber
Jordan F. Karp
Abdus S. Wahed
4
+ PDF Chat An experimental design for the development of adaptive treatment strategies 2004 Susan A. Murphy
4
+ ORDERING PROPERTIES OF ORDER STATISTICS FROM HETEROGENEOUS POPULATIONS: A REVIEW WITH AN EMPHASIS ON SOME RECENT DEVELOPMENTS 2013 N. Balakrishnan
Peng Zhao
4
+ Stochastic comparisons of parallel systems of heterogeneous exponential components 1997 Richard L. Dykstra
Subhash C. Kochar
Javier Rojo
4
+ Some characterization results for parallel systems with two heterogeneous exponential components 2010 Peng Zhao
N. Balakrishnan
4
+ PDF Chat Stochastic Order Relations Among Parallel Systems from Weibull Distributions 2015 Nuria Torrado
Subhash C. Kochar
4
+ Two-stage selection and testing designs for comparative clinical trials 1988 Peter F. Thall
Richard Simon
Susan S. Ellenberg
4
+ PDF Chat Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical Trials 2016 Shing M. Lee
Daniel Backenroth
Ying Kuen Cheung
Dawn L. Hershman
Diana Vulih
Barry Anderson
Percy Ivy
Lori M. Minasian
4
+ PDF Chat Marginal Mean Models for Dynamic Regimes 2001 Susan A. Murphy
Mark J. van der Laan
James M. Robins
4
+ Further results for parallel systems with two heterogeneous exponential components 2012 Rongfang Yan
Gaofeng Da
Peng Zhao
3
+ PDF Chat Seamless Phase I/II Adaptive Design for Oncology Trials of Molecularly Targeted Agents 2014 Nolan A. Wages
Christopher Tait
3
+ PDF Chat Adaptive designs for identifying optimal biological dose for molecularly targeted agents 2014 Yong Zang
J. Jack Lee
Ying Yuan
3
+ PDF Chat Simultaneous Confidence Intervals for all Distances from the "Best" 1981 Jason C. Hsu
3
+ A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect 1986 James M. Robins
3
+ Some new results on stochastic comparisons of parallel systems 2000 ‎Baha-Eldin Khaledi
Subhash C. Kochar
3
+ Stochastic comparisons of order statistics from heterogeneous populations, with applications in reliability 1976 Frank Proschan
Jayaram Sethuraman
3
+ A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials 2019 Xiaobo Zhong
Bin Cheng
Min Qian
Ying Kuen Cheung
3
+ A Unified Theory of Two-Stage Adaptive Designs 2002 Qing Liu
Michael A. Proschan
Gordon Pledger
3
+ PDF Chat Bayesian Dose Finding by Jointly Modelling Toxicity and Efficacy as Time-to-Event Outcomes 2009 Ying Yuan
Guosheng Yin
3
+ STOCHASTIC COMPARISONS OF PARALLEL SYSTEMS WHEN COMPONENTS HAVE PROPORTIONAL HAZARD RATES 2007 Subhash C. Kochar
Maochao Xu
3
+ Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts 2006 Frank Bretz
Heinz Schmidli
Franz König
Amy Racine
Willi Maurer
3
+ PDF Chat Dose-finding designs for trials of molecularly targeted agents and immunotherapies 2017 Codruța Chiuzan
Jonathan Shtaynberger
Gulam A. Manji
Jimmy Duong
Gary K. Schwartz
Anastasia Ivanova
Shing M. Lee
3
+ Phase I Trials of Molecularly Targeted Agents: Should We Pay More Attention to Late Toxicities? 2011 Sophie Postel‐Vinay
Carlos Gomez‐Roca
L Rhoda Molife
B. Anghan
Antonin LĂ©vy
Ian Judson
Johann S. de Bono
Jean‐Charles Soria
Stan B. Kaye
Xavier PaolettĂ­
3
+ PDF Chat New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes 2014 Ying-Qi Zhao
Donglin Zeng
Eric B. Laber
Michael R. Kosorok
3
+ Determining the optimal dose in the development of anticancer agents 2014 Ron H.J. Mathijssen
Alex Sparreboom
Jaap Verweij
3
+ Adaptive Seamless Designs: Selection and Prospective Testing of Hypotheses 2007 Christopher Jennison
Bruce W. Turnbull
3
+ Point estimates and confidence regions for sequential trials involving selection 2004 Nigel Stallard
Susan Todd
3
+ PDF Chat Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities 2000 Ying Kuen Cheung
Rick Chappell
3
+ Some properties of hazard rate functions of systems with two components 2009 Sui Joo
Jie Mi
3
+ PDF Chat Sample size calculations for evaluating treatment policies in multi-stage designs 2010 Ree Dawson
Philip W. Lavori
3
+ Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents – Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group for Early Trials of Targeted therapies, an European Organisation for Research and Treatment of Cancer-led study 2014 Sophie Postel‐Vinay
Laurence Collette
Xavier PaolettĂ­
Elisa Rizzo
Christophe Massard
David Olmos
Camilla Fowst
Bernard LĂ©vy
Pierre Mancini
Denis Lacombe
3
+ Multiple Test Procedures for Dose Finding 1996 Ajit C. Tamhane
Yosef Hochberg
Charles W. Dunnett
2
+ PDF Chat Efficient design and inference for multistage randomized trials of individualized treatment policies 2011 Ree Dawson
Philip W. Lavori
2
+ An adaptive dose-finding design incorporating both toxicity and efficacy 2005 Wei Zhang
Daniel J. Sargent
Sumithra J. Mandrekar
2
+ Consistency of continual reassessment method under model misspecification 1996 Larry Z. Shen
John O’Quigley
2
+ PDF Chat The Conjugate Gradient Method and Trust Regions in Large Scale Optimization 1983 Trond Steihaug
2
+ Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial 2004 B. Nebiyou Bekele
Peter F. Thall
2
+ Sequential designs for phase III clinical trials incorporating treatment selection 2003 Nigel Stallard
Susan Todd
2
+ PDF Chat A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method 2002 Ying Kuen Cheung
Rick Chappell
2
+ PDF Chat Estimating Individualized Treatment Rules Using Outcome Weighted Learning 2012 Ying‐Qi Zhao
Donglin Zeng
A. John Rush
Michael R. Kosorok
2
+ A survey of truncated-Newton methods 2000 Stephen G. Nash
2
+ Cancer phase I clinical trials: efficient dose escalation with overdose control 1998 James S. Babb
André Rogatko
Shelemyahu Zacks
2
+ PDF Chat Interactive model building for Q-learning 2014 Eric B. Laber
Kristin A. Linn
Leonard A. Stefanski
2
+ PDF Chat Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach 2008 Anastasia Ivanova
Se Hee Kim
2
+ Group Sequential Methods with Applications to Clinical Trials 1999 Christopher Jennison
Bruce W. Turnbull
2
+ MRL ordering of parallel systems with two heterogeneous components 2010 Peng Zhao
N. Balakrishnan
2
+ PDF Chat Multiple Comparisons with the Best Treatment 1983 Donald G. Edwards
Jason C. Hsu
2